Our data showed that m-THPC-PDT and VP-PDT treatment induced autophagy in CRC cells, as shown by an increased ratio of MAP1LC3B-II/MAP1LC3B-I and the degradation of the SQSTM1/p62 protein. The gene discussed is MAP1LC3B; the disease is colorectal carcinoma.